Asset Details
Do you wish to reserve the book?
Citrullinated Histone H3 as a Therapeutic Target for Endotoxic Shock in Mice
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Citrullinated Histone H3 as a Therapeutic Target for Endotoxic Shock in Mice
Do you wish to request the book?
Citrullinated Histone H3 as a Therapeutic Target for Endotoxic Shock in Mice
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Citrullinated Histone H3 as a Therapeutic Target for Endotoxic Shock in Mice
2020
Overview
Sepsis results in millions of deaths every year, with acute lung injury (ALI) being one of the leading causes of mortality in septic patients. As neutrophil extracellular traps (NETs) are abundant in sepsis, neutralizing components of NETs may be a useful strategy to improve outcomes of sepsis. Citrullinated histone H3 (CitH3) has been recently shown to be involved in the NET formation. In this study, we demonstrate that CitH3 damages human umbilical vein endothelial cells (HUVECs) and potentiates NET formation through a positive feedback mechanism. We developed a novel CitH3 monoclonal antibody to target peptidylarginine deiminase (PAD) 2 and PAD 4 generated CitH3. In a mouse model of lethal lipopolysaccharide (LPS) induced shock, neutralizing CitH3 with the newly developed anti-CitH3 monoclonal antibody attenuates inflammatory responses, ameliorates ALI, and improves survival. Our study suggests that effectively blocking circulating CitH3 might be a potential therapeutic method for the treatment of endotoxemia.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Animals
/ Antibodies, Monoclonal - administration & dosage
/ DNA
/ Extracellular Traps - immunology
/ Histones
/ Humans
/ Male
/ Mice
/ neutrophil extracellular traps
/ Peptides
/ Protein-Arginine Deiminase Type 2 - immunology
/ Protein-Arginine Deiminase Type 4 - immunology
/ Proteins
/ Sepsis
/ Shock
We currently cannot retrieve any items related to this title. Kindly check back at a later time.